Kansas City, Mo., May 1, 2012 – Kansas City Southern (KCS) (NYSE: KSU) is pleased to announce that its subsidiary, The Kansas City Southern Railway Company (KCSR), received the American Chemistry Council’s (ACC) Responsible Care® Partner Award on April 30 at the 21st annual Responsible Care Conference and Expo in Hollywood, Fla.
“KCSR is honored to have been selected for this prestigious award,” said KCS president and chief executive officer David L. Starling. “Moving our customer’s freight in a safe and secure manner everyday is a priority for the KCS teams in both the U.S. and Mexico.”
KCSR was among three companies to receive the Responsible Care Partner Award, which recognizes the performance and excellent safety record of companies involved in the distribution, transportation, storage, use, treatment-disposal and/or sales and marketing of chemicals. ACC Responsible Care® award winners are selected by an external expert committee.
Responsible Care® is the chemical industry's world-class environmental, health, safety and security performance initiative. For nearly 25 years, Responsible Care has helped ACC member companies significantly enhance their performance and reputation, discover new business opportunities, and improve the health and safety of their employees and communities and the environment as a whole.
Headquartered in Kansas City, Mo., KCS is a transportation holding company that has railroad investments in the U.S., Mexico and Panama. Its primary U.S. holding is The Kansas City Southern Railway Company, serving the central and south central U.S. Its international holdings include Kansas City Southern de Mexico, S.A. de C.V., serving northeastern and central Mexico and the port cities of Lázaro Cárdenas, Tampico and Veracruz, and a 50 percent interest in Panama Canal Railway Company, providing ocean-to-ocean freight and passenger service along the Panama Canal. KCS’ North American rail holdings and strategic alliances are primary components of a NAFTA Railway system, linking the commercial and industrial centers of the U.S., Mexico and Canada.